California · Nonprofit
NEUROENDOCRINE CANCER FOUNDATION
NEUROENDOCRINE CANCER FOUNDATION (California) receives grants from 6 organizations whose IRS filings report $133,601 to it, the largest being FIDELITY INVESTMENTS CHARITABLE GIFT FUND ($94,483). 3 of them have funded it in more than one year, and 83% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.
- Revenue FY2024
- $419k
- Funders on record
- 6
- Grants received
- $134k
- Net assets
- $772k
What Neuroendocrine Cancer Foundation does
Mission
The mission of the Neuroendocrine Cancer Foundation is to provide a community of support and education for patients and to advocate for all people impacted by this rare disease by expanding awareness and voicing the patient's perspective in collaborative (cont. Sch. O) dialogue with healthcare professionals.
As stated on its FY2024 Form 990.
Program
Founded in 2012, the Neuroendocrine Cancer Foundation (ncf), previously known as lacnets, presents leading neuroendocrine tumor (net) experts in oncology, gastroenterology, radiology, nuclear medicine, clinical trials, pain management, surgery, pathology, endocrinology and palliative care. Neuroendocrine Cancer Foundation also addresses patient concerns in the areas of nutrition, advocacy, caregiving supportive care, and wellbeing. During 2024, ncf reached more than 100,000 people globally. Ncf's educational programs included over 40 doctors, health care professionals, patients and experts as presenters or panelists. (cont. On sch. O)in 2024, ncf hosted ten virtual educational events and three in-person events on a wide variety of net topics including treatments, symptoms, clinical trials, caregiving, health coaching, coping, and advance care planning. Ncf hosted a virtual conference in june 2024 featuring net experts, a live q&a, a nets 101 session for the newly diagnosed, and patient stories. Ncf hosts a virtual weekly support group for patients and caregivers. With an attendance of 35-40 participants each week, this group is a safe space to come together for community and…
$213,749 spent$25,200 earned by the program100% of program spending
The program described on its FY2024 Form 990. Program spending in total: $213,749.
The organization over time
Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.
Balance sheet
Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2019 to 2020, from $236k to $413k (+75%).
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
Government-grant reliance: 2021 6%. Grants only. Government contracts and fees sit inside program revenue.
90% of NEUROENDOCRINE CANCER FOUNDATION’s revenue is contributions — more donation-reliant than the typical peer (82% for the typical peer).
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 0 of the last 8 reported years ran a deficit.
reserve
Leadership and staff
The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.
Chief executive
Kavya Velagapudi
Director, executive director, treasurer
As listed on its FY2024 Form 990.
Who funds it, year by year
2019 → 2023: the base held at 1 funder, grant income rose $6k → $12k.
4 of 6 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 83% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.
From the IRS filings of NEUROENDOCRINE CANCER FOUNDATION’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How concentrated its funding is
NEUROENDOCRINE CANCER FOUNDATION leans on a few funders — its largest provides 71% of grant income and the top three 92%; half comes from just 1 funder.
the vertical line marks half of all grant income — 1 funder to its left
83% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund NEUROENDOCRINE CANCER FOUNDATION.
Largest funder’s share by year: 2019 100% · 2020 99% · 2021 38% · 2022 100% · 2023 100% — broadly stable.
“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Where its funders are
83% of NEUROENDOCRINE CANCER FOUNDATION's grant income arrives through donor-advised or pass-through sponsors, whose addresses record where the money is held rather than where the donor is. Of the $23k that is directly attributable, 100% of it comes from California funders.
In-state vs out-of-state, by year
Funder states come from each funder’s own filing. $111k arriving through sponsors registered in 4 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Against its field
NEUROENDOCRINE CANCER FOUNDATION runs a healthier operating margin than three-quarters of the 13,754 health nonprofits its size.
this organization peer median middle 50% of peers· 13,754 health nonprofits $100k–$1M, FY2024
Organizations like NEUROENDOCRINE CANCER FOUNDATION
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In California
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Where the money goes
84% of spending goes to programs.
Governance
Public support
54%
Share of support from the public (Schedule A) — the basis for its public-charity status.
Footprint & structure
Files a return copy in 1 state
Screen this organization
A dated, signed PDF of the compliance screen for NEUROENDOCRINE CANCER FOUNDATION: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds NEUROENDOCRINE CANCER FOUNDATION?
- NEUROENDOCRINE CANCER FOUNDATION (California) receives grants from 6 organizations whose IRS filings report $133,601 to it, the largest being FIDELITY INVESTMENTS CHARITABLE GIFT FUND ($94,483). 3 of them have funded it in more than one year, and 83% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.
- How many funders does NEUROENDOCRINE CANCER FOUNDATION have?
- IRS filings report 6 organizations giving $133,601 in grants to NEUROENDOCRINE CANCER FOUNDATION, 3 of which have funded it in more than one year.
- Who is the largest funder of NEUROENDOCRINE CANCER FOUNDATION?
- FIDELITY INVESTMENTS CHARITABLE GIFT FUND is the largest funder on record, with $94,483 in grants. The full list of funders is on this page.
- How can an organization like NEUROENDOCRINE CANCER FOUNDATION find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in California. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
Play a game about who funds Neuroendocrine Cancer →
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2024 (financials across 2017–2024), and the filings of 6 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing